Immune Deficiency Foundation

Please DONATE today

 
 
Patients & Families
Peer Support Patient Education
Programs
Health Insurance
Services
Ask IDF Clinical Trial
Opportunities
Scholarship Program USIDNET Contact Us
Healthcare Professionals
Consulting Immunologist
Program
LeBien Visiting
Professor Program
Nurse Advisory
Committee
Links - Professional
Organizations
USIDNET Contact Us
How You Can Help
Make a Donation Volunteer Blue Jeans for
Healthy Genes
  • About IDF
  • About Primary Immunodeficiencies
    • What is a Primary Immunodeficiency Disease?
    • Publications
  • Public Policy
    • Public Policy Program
    • Grassroots Advocacy
    • IVIG Access & Reimbursement
    • IDF Public Policy Activity
    • Action Alert
  • Immunoglobulin Information
    • Immune Globulin Products
    • Product Recalls
    • Patient Notification System
  • IDF Publications
  • IDF Surveys
    • About
    • Capabilities
    • IDF Surveys
  • IDF Resources
  • News
  • Calendar of Events
  • Discussion Forum
  • IDF Core Sponsors
  • Contact Us
    • Patients' Form
    • Medical Professionals' Form
  • IDF Store
 GO

Site funding provided by:  Telecris Biotheraputics

IDF Surveys

  • Patient Surveys
    • (1995) Primary Immune Deficiency Disease in America: The first national survey of patients and specialists
    • (2002) Primary Immune Deficiency Disease in America: The second national survey of patients
    • (2003) Treatment Experiences and Preferences of Patients with Primary Immune Deficiency Diseases: First national survey
  • IVIG Access Surveys
    • (2006) Assessing the Impact of Changes in Reimbursement Regulations and Product Availability on Access to Intravenous Gammaglobulin Treatment Among Primary Immune Deficiency Patients
    • (2006) The Immune Deficiency Foundation and American Academy of Allergy, Asthma and Immunology Immunologist Survey Regarding IVIG Treatment
    • (2006) Hospital Usage of Intravenous Immunoglobulin: A 2006 survey of pharmacy directors
  • Published Reports
    • Population Prevalence of Diagnosed Primary Immunodeficiency Diseases in the United States
    • Impact of intravenous immunoglobulin (IVIG) treatment among patients with Primary Immunodeficiency diseases

If you would like more information, please call IDF's Director of Survey Research at 800.296.4433 or idf@primaryimmune.org.

Immune Deficiency Foundation 40 West Chesapeake Avenue, Suite 308 Towson, Maryland 21204 ©2008 IDF
1-800-296-4433 idf@primaryimmune.org

  • disclaimer
  • site map